Introduction:
The biosimilar market in India is rapidly growing, with several emerging firms making a significant impact on the industry. According to recent statistics, the biosimilar market in India is expected to reach a value of $2.2 billion by 2026, driven by increasing demand for affordable biologic drugs. In this report, we will highlight the top 10 emerging biosimilar firms in India that are poised for success in 2026.
Top 10 Emerging Biosimilar Firms in India 2026:
1. Biocon Limited
Biocon Limited is a leading biopharmaceutical company in India, specializing in the development and manufacturing of biosimilar products. With a production volume of over 200,000 units per year, Biocon holds a significant market share in the biosimilar industry. The company’s strong pipeline of biosimilar products and strategic partnerships make it a key player in the market.
2. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is another prominent player in the Indian biosimilar market, with a focus on producing high-quality and cost-effective biosimilar drugs. The company’s biosimilar portfolio covers a wide range of therapeutic areas, including oncology and autoimmune diseases. Dr. Reddy’s Laboratories has been expanding its global presence, with exports accounting for 30% of its total revenue.
3. Zydus Cadila
Zydus Cadila is a well-established pharmaceutical company in India, known for its expertise in biosimilar research and development. The company’s biosimilar products have gained recognition for their efficacy and affordability, making them a preferred choice among healthcare providers. Zydus Cadila’s biosimilar division has been growing steadily, with a market share of 15% in India.
4. Intas Pharmaceuticals
Intas Pharmaceuticals is a rapidly growing player in the biosimilar market, with a strong focus on innovation and quality. The company’s biosimilar products have been well-received in the market, leading to a significant increase in production volume. Intas Pharmaceuticals is committed to expanding its biosimilar portfolio to address unmet medical needs in India and beyond.
5. Lupin Limited
Lupin Limited is a leading pharmaceutical company in India, with a growing presence in the biosimilar market. The company’s biosimilar division has been gaining traction, driven by the launch of several key products. Lupin Limited’s biosimilar exports have been increasing steadily, contributing to its overall revenue growth.
6. Cipla Limited
Cipla Limited is a renowned pharmaceutical company in India, with a strong focus on biosimilar research and development. The company’s biosimilar products have been instrumental in addressing the healthcare needs of patients across various therapeutic areas. Cipla Limited’s biosimilar division has shown significant growth potential, supported by strategic collaborations and partnerships.
7. Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is a leading player in the biosimilar market, known for its innovative approach to drug development. The company’s biosimilar portfolio includes products for chronic diseases such as diabetes and cardiovascular disorders. Glenmark Pharmaceuticals has been expanding its biosimilar production capacity, aiming to meet the growing demand for affordable biologic drugs.
8. Aurobindo Pharma
Aurobindo Pharma is a well-established pharmaceutical company in India, with a strong presence in the biosimilar market. The company’s biosimilar division has been growing steadily, driven by the launch of several key products. Aurobindo Pharma’s biosimilar exports have been increasing, positioning the company as a key player in the global biosimilar market.
9. Torrent Pharmaceuticals
Torrent Pharmaceuticals is a prominent player in the Indian biosimilar market, known for its diverse portfolio of high-quality products. The company’s biosimilar division has been expanding rapidly, with a focus on addressing the healthcare needs of patients in India and abroad. Torrent Pharmaceuticals’ biosimilar production volume has been increasing, reflecting the company’s commitment to innovation and quality.
10. Sun Pharmaceutical Industries
Sun Pharmaceutical Industries is a leading pharmaceutical company in India, with a strong presence in the biosimilar market. The company’s biosimilar products have gained recognition for their efficacy and affordability, making them a preferred choice among healthcare providers. Sun Pharmaceutical Industries’ biosimilar exports have been growing steadily, contributing to its overall revenue growth.
Insights:
The biosimilar market in India is poised for significant growth in the coming years, driven by increasing demand for affordable biologic drugs. With the emergence of several top players in the industry, competition is expected to intensify, leading to greater innovation and market expansion. By focusing on research and development, strategic partnerships, and global market penetration, the top 10 emerging biosimilar firms in India are well-positioned to capitalize on the growing opportunities in the biosimilar market. According to industry forecasts, the biosimilar market in India is projected to grow at a CAGR of 25% from 2021 to 2026, reaching a value of $2.2 billion by the end of the forecast period. This growth trajectory underscores the immense potential of the biosimilar market in India and the significant role that emerging firms will play in shaping its future.
Related Analysis: View Previous Industry Report
